- Home
- FHTX vs RLTY Comparison
FHTX vs RLTY Comparison
Compare FHTX & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHTX | RLTY |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.4M | 268.0M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FHTX | RLTY |
|---|---|---|
| Price | $5.40 | $15.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 376.3K | 67.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.35% |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,909,000.00 | N/A |
| Revenue This Year | $8.89 | N/A |
| Revenue Next Year | $20.13 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $3.27 | $14.04 |
| 52 Week High | $6.95 | $16.11 |
Technical Indicators
Market Signals| Indicator | FHTX | RLTY |
|---|---|---|
| Relative Strength Index (RSI) | 60.26 | 54.14 |
| Support Level | $5.22 | $15.33 |
| Resistance Level | $5.70 | $15.90 |
| Average True Range (ATR) | 0.48 | 0.21 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 57.15 | 63.93 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income. Its secondary investment objective is capital appreciation. The fund invests the majority of its managed assets in real estate-related investments and preferred and other income securities.